1. Home
  2. NE vs PRAX Comparison

NE vs PRAX Comparison

Compare NE & PRAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Noble Corporation plc A

NE

Noble Corporation plc A

HOLD

Current Price

$40.54

Market Cap

8.0B

ML Signal

HOLD

Logo Praxis Precision Medicines Inc.

PRAX

Praxis Precision Medicines Inc.

HOLD

Current Price

$312.35

Market Cap

7.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NE
PRAX
Founded
1985
2015
Country
United States
United States
Employees
4500
N/A
Industry
Other Specialty Stores
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
8.0B
7.1B
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
NE
PRAX
Price
$40.54
$312.35
Analyst Decision
Buy
Strong Buy
Analyst Count
7
15
Target Price
$46.00
$572.13
AVG Volume (30 Days)
1.7M
328.5K
Earning Date
04-26-2026
05-08-2026
Dividend Yield
3.98%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$9.18
$7,758.26
P/E Ratio
$32.79
N/A
Revenue Growth
N/A
N/A
52 Week Low
$26.20
$37.25
52 Week High
$54.98
$366.52

Technical Indicators

Market Signals
Indicator
NE
PRAX
Relative Strength Index (RSI) N/A N/A
Support Level N/A N/A
Resistance Level N/A N/A
Average True Range (ATR) 0.00 0.00
MACD 0.00 0.00
Stochastic Oscillator 0.00 0.00

Price Performance

Historical Comparison
NE
PRAX

About NE Noble Corporation plc A

Noble Corp PLC is an offshore drilling contractor for the oil and gas industry that provides contract drilling services to the international oil and gas industry with its fleet of mobile offshore drilling units. The company focuses on a high-specification fleet of floating and jackup rigs and on deploying its drilling rigs in oil and gas basins around the world. The mobile offshore drilling units comprising the offshore rig fleet operate in international markets for contract drilling services and are often redeployed to different regions due to changing customer demand, which consists mainly of large, integrated, independent, and government-owned or controlled oil and gas companies throughout the world.

About PRAX Praxis Precision Medicines Inc.

Praxis Precision Medicines Inc is a clinical-stage biopharmaceutical company. It is engaged in translating genetic insights into the development of therapies for patients affected by central nervous system disorders characterized by a neuronal excitation-inhibition imbalance. The company applies genetic insights to the discovery and development of therapies for neurological disorders through two proprietary platforms: Cerebrum and Solidus. It has established a diversified, multimodal CNS portfolio with four clinical-stage product candidates across movement disorders and epilepsy, which include Ulixacaltamide, Relutrigine, Vormatrigine, and Elsunersen. The firm operates in only one segment and is focused on discovering and developing therapies for CNS disorders.

Share on Social Networks: